10:00 – 10:10 a.m.

Opening of Steering Committee Meeting

• Joshua LaBaer, MD, PhD, Arizona State University/The Biodesign Institute
• Arul Chinnaiyan, MD, PhD, University of Michigan Medical School

10:10 – 10:40 a.m.

01: State of EDRN

Sudhir Srivastava, PhD, MPH, National Cancer Institute

10:40 a.m. – 10:50 a.m.

Q&A

10:50 a.m.–4:30 p.m.

10:50 a.m. - 10: 55 a.m.

Presentations by Recently Funded EDRN BCCs and CVCs

Introduction: Sudhir Srivastava, PhD, MPH, National Cancer Institute

10:55 a.m. - 11:20 a.m.

02: Southwest EDRN Clinical Validation Center for Head and Neck Cancer

• Erich Sturgis, MD, MPH, Baylor College of Medicine
• Karen Anderson, MD, PhD, Arizona State University/The Biodesign Institute

11:20 a.m. – 11:25 a.m.

Q&A

11:25 a.m. – 11:50 a.m.

03: Clinical Validation Center for Early Detection of Ovarian Cancer with a Multiple Marker Algorithm

Robert Bast, MD, The University of Texas MD Anderson Cancer Center

11:50 a.m. – 11:55 a.m.

Q&A

11:55 a.m.–12:40 p.m.

Break

12:40 p.m. – 1:05 p.m.

04: Validation of Biomarkers for Risk Prediction and Early Diagnosis of Pancreatic Adenocarcinoma

• Randal Brand, MD, University of Pittsburgh
• Surinder Batra, PhD, University of Nebraska

1:05 p.m. – 1:10 p.m.

Q&A

1:10 p.m. – 1:35 p.m.

05:Quantitative Imaging Clinical Validation Center at Moffitt Cancer Center

• John Heine, PhD, H. Lee Moffitt Cancer Center & Research Institute
• Matthew Schabath, PhD, H. Lee Moffitt Cancer Center & Research Institute

1:35 p.m.– 1:40 p.m.

Q&A

1:40 p.m. – 2:05 p.m.

06: Prostate Cancer Biomarker and Imaging Validation Alliance Emory University, University of Alabama Birmingham, and University of Texas Southwestern

Martin Sanda, MD, Emory University

2:05 p.m.– 2:10 p.m.

Q&A

2:10 p.m. – 2:35 p.m.

07: DNA Evaluation of Fragments for Early Interception (DELFI) of Lung Cancer

• Victor Velculescu, MD, PhD, Johns Hopkins University
• David Sidransky, MD, Johns Hopkins University

2:35 p.m. – 2:40 p.m.

Q&A

2:40 – 3:00 p.m.

Break

3:00 p.m. – 3:25 p.m.

08: BCC for Prostate Cancer: Discovery and Translation of Biomarkers for Clinical Unmet Needs

• Daniel Chan, PhD, Johns Hopkins University
• Hui Zhang, PhD, Johns Hopkins University

3:25 p.m. – 3:30 p.m.

Q&A

3:30 p.m. – 3:55 p.m.

09: Breast-Cancer Focused Biomarker Characterization Center Employing Targeted Mass Spec Assays in a CLIA Environment

• Amanda Paulovich, MD, PhD, Fred Hutchinson Cancer Center
• Andrew Hoofnagle, MD, PhD, University of Washington
• Pei Wang, PhD, Icahn School of Medicine at Mount Sinai

3:55 p.m. – 4: 00 p.m.

Q&A

4:00 p.m. – 4:25 p.m

10: Microbial and Host Biomarker Development for Detection and Prognosis of Early-Stage Non-Small Cell Lung Cancer

• Leopoldo Segal, MD, New York University Grossman School of Medicine
• Harvey Pass, MD, New York University Grossman School of Medicine

4:25 p.m. – 4:30 p.m

Q&A

4:30 – 5:00 p.m.

Vote for EDRN Steering Committee Chair and Co-Chair (secret ballot)